Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

Cancer drug price caps: Why Jefferies picks Fortis, Apollo, Manipal despite SC scrutiny

Posted on October 9, 2026
By Financial Express
0 Views
1 min read

In brief

Generating AI summary…

Cancer drug price caps: Why Jefferies picks Fortis, Apollo, Manipal despite SC scrutiny

Jefferies remains constructive on hospital stocks despite proposed cancer drug price caps. Here is why Fortis Healthcare, Manipal Hospitals, Apollo Hospitals, Max Healthcare and Medanta are among its preferred picks.